C4 Therapeutics (CCCC) Proxy filing summary

Voting matters and shareholder proposals

• Election of three Class III directors to serve until the 2029 Annual Meeting, with nominees Andrew Hirsch, Stephen Fawell, Ph.D., and Utpal Koppikar.

• Advisory vote to approve the compensation of named executive officers.

• Ratification of KPMG LLP as independent registered public accounting firm for the year ending December 31, 2026.

• Approval of an amendment to the 2020 Stock Option and Incentive Plan to include outstanding pre-funded warrants in the share count for the evergreen provision.

• Proxies authorized to vote on any other business properly brought before the meeting.

Board of directors and corporate governance

• Board recommends voting in favor of all proposals, including director elections and plan amendments.

Executive compensation and say-on-pay

• Advisory vote scheduled for shareholder approval of executive officer compensation.